Erratum (Retracted Article): Blockage of intracellular proton extrusion with proton pump inhibitor induces apoptosis in gastric cancer (Cancer Science)

Cancer Science

Volumn 99, Issue 1, 2008, Pages 185-

  Yeo, Marie ^a   Kim, Dong Kyu ^a   Park, Hee Jin ^a   Cho, Sung Won ^a   Cheong, Jae Youn ^a   Lee, Kwang Jae ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE; ERRATUM; APOPTOSIS; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; MITOCHONDRION; PATHOLOGY; PH; PHOSPHORYLATION; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; CASPASE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CULTURE MEDIA; ENZYME ACTIVATION; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; HYDROGEN-ION CONCENTRATION; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OMEPRAZOLE; PHOSPHORYLATION; PROTON PUMP INHIBITORS; STOMACH NEOPLASMS;

EID: 36948999655     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: None     Document Type: TB

References (36)

1. Scott DR, Helander HF, Hersey SJ et. al. The site of acid secretion in the mammalian parietal cell. Biochim Biophys Acta Bio-Membr 1993; 1146: 73-80.
2. Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy 1997; 17: 22-37.
3. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51: 460-82.
4. +-ATPase. Ann Rev Pharmacol Toxicol 1995; 35: 277-305.
5. Horn J. The proton-pump inhibitors: Similarities and differences. Clin Ther 2000; 22: 266-80.
6. Lamberts R, Creutzfeldt W, Struber HG et. al. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104: 1356-70.
7. Jansen JB, Klinkenberg-Knol EC, Meuwissen SG et. al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990; 99: 621-8.
8. Hakanson R, Tielemans Y, Chen D et. al. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 1993; 105: 15-21.
9. Dockray GJ, Varro A, Dimaline R et. al. The gastrins: Their production and biological activities. Annu Rev Physiol 2001; 63: 119-39.
10. Koh TJ, Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept 2000; 93: 37-44.
11. Viani F, Siegrist HH, Pignatelli B et. al. The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. Eur J Gastroenterol Hepatol 2000; 12: 165-73.
12. Lamberts R, Brunner G, Solcia E. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa. Digestion 2001; 64: 205-13.
13. Kuipers EJ, Meuwissen SG. The efficacy and safety of long-term omeprazole treatment for gastroesophageal reflux disease. Gastroenterology 2000; 118: 795-8.
14. Klinkenberg-Knol EC, Nelis F, Dent J et. al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000; 118: 661-9.
15. Laine L, Ahnen D, McClain C et. al. Review article: Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 651-68.
16. Stubbs M, McSheeh PM, Griffiths JR. Causes and consequences of acidic pH in tumors: A magnetic resonance study. Adv Enzyme Regul 1999; 39: 13-30.
17. Suubbs M, Rodrigues LM, Howe FA et. al. The metabolic consequences of a reversed pH gradient in rat tumors. Cancer Res 1994; 54: 4011-6.
18. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989; 49: 4373-84.
19. Helmlinger G, Yuan F, Dellian M et. al. Interstitial pH and pO2 gradients in solid tumor in vivo: High resolution measurements reveal a lack of correlation. Nat Med 1997; 3: 177-82.
20. Spicer Z, Miller ML, Andringa A et. al. Stomachs of mice lacking the gastric H, K-ATPase alpha-subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J Biol Chem 2000; 275: 2555-65.
21. Judd LM, Alderman BM, Howlett M et. al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004; 126: 196-207.
22. Zavros Y, Eaton KA, Kang W et. al. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 2005; 24: 2354-66.
23. Yeo M, Kim DK, Kim YB et. al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 2004; 10: 8687-96.
24. Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006; 18: 598-608.
25. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, the metabolic microenvironment of human tumors: A review. Cancer Res 1989; 49: 6449-65.
26. + exchangers. Physiol Rev 1997; 77: 51-74.
27. +-ATPase: A universal proton pump of eukaryotes. Biochem J 1997; 324: 697-712.
28. +-ATPase inhibitor in B lineage cells. J Cellular Physiol 2002; 186: 65-72.
29. +)-atpases. J Pharmacol Exp Ther 2001; 297: 114-20.
30. Shchepina LA, Pletjushkina OY, Avetisyan AV et. al. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene 2002; 21: 8149-57.
31. +)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anticancer Drugs 2002; 13: 237-43.
32. +)- translocating ATPases. Biochim Biophys Acta 1991; 1065: 261-8.
33. +)-ATPase. Biochem Biophys Res Commun 1993; 196: 699-706.
34. +)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole. Am J Physiol 1994; 266: F868-77.
35. Yeo M, Kim DK, Han SU et. al. Novel action of gastric proton pump inhibitor on suppression of H. pylori induced angiogenesis. Gut 2006; 55: 26-33.
36. Yeo M, Kim DK, Chung IS et. al. The novel acid pump antagonists for anti-secretory actions with their peculiar applications beyond acid suppression. J Clin Biochem Nutr 2006; 38: 1-8.